Bill Information for SB 941
Pharmaceutical products; requiring manufacturers to publish certain list of ingredients; providing administrative, civil, and criminal penalties and remedies. Effective date.
|
History For SB 941 |
Action
|
Journal Page
|
Date
|
Chamber
|
| First Reading |
240 |
02/03/2025 |
S |
|
| Authored by Senator Deevers |
240 |
02/03/2025 |
S |
|
| Second Reading referred to Health and Human Services |
311 |
02/04/2025 |
S |
|
|
Floor Amendments (Senate) |
| None |
Floor Amendments (House) |
| None |
Committee Amendments (Senate) |
| None |
Committee Amendments (House) |
| None |
Sub Committee OR Policy Committee Recommendations (House) |
| None |
|
Bill Summaries/Fiscal Impact for SB 941 (House) |
| None |
Bill Summaries/Fiscal Impact for SB 941 (Senate) |
| Introduced |
1/22/2025 |
|
OPLAA Actuarial Statements For SB 941 (House) |
| None |
OPLAA Actuarial Statements For SB 941 (Senate) |
| None |
Fiscal Impact Statements For SB 941 (House) |
| None |
Fiscal Impact Statements For SB 941 (Senate) |
| None |
|
Versions of SB 941 |
| Introduced |
1/16/2025 |
|
Committee Reports for SB 941 |
Conference Committee Reports for SB 941 |
|
Authors/Co Authors for SB 941 |
|
***To be added when the next official action is taken on the measure.***
|
|
Address: 2300 N Lincoln Blvd., State Capitol Building, Oklahoma City, OK 73105